BVF Inc’s Mirum Pharmaceuticals MIRM Stock Holding History

BVF Inc’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124M	Sell	1,056,027 -528,700	-33%	-$53.1M	3.16%	8
2026 Q1	$146M	Buy	1,584,727 +89,437	+6%	+$8.41M	4.66%	6
2025 Q4	$118M	Hold	1,495,290	–	–	3.98%	6
2025 Q3	$110M	Sell	1,495,290 -1,266,043	-46%	-$80.5M	4.44%	7
2025 Q2	$141M	Sell	2,761,333 -35,180	-1%	-$1.57M	5.02%	6
2025 Q1	$126M	Hold	2,796,513	–	–	5.13%	5
2024 Q4	$116M	Sell	2,796,513 -279,394	-9%	-$11.6M	3.92%	5
2024 Q3	$120M	Sell	3,075,907 -1,294,117	-30%	-$51.6M	3.51%	4
2024 Q2	$149M	Hold	4,370,024	–	–	4.19%	5
2024 Q1	$110M	Hold	4,370,024	–	–	3.02%	7
2023 Q4	$129M	Hold	4,370,024	–	–	3.23%	6
2023 Q3	$138M	Buy	+4,370,024	New	+$120M	3.72%	5
2022 Q1	–	Sell	-435,936	Closed	-$6.95M	–	83
2021 Q4	$6.95M	Hold	435,936	–	–	0.25%	61
2021 Q3	$8.68M	Buy	+435,936	New	+$7.09M	0.34%	57

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BVF Inc's MIRM Position: Q2 2026 in Review

BVF Inc reduced its Mirum Pharmaceuticals (MIRM) stake by 33% in Q2 2026, selling an estimated $53.1M and leaving 1,056,027 shares worth $124M. The position accounts for 3.16% of the portfolio, ranked #8.

BVF Inc first reported a position in MIRM in Q3 2021 and has held it in 14 quarters since. The position peaked at $149M in Q2 2024. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

BVF Inc held 1,056,027 shares of Mirum Pharmaceuticals worth $124M as of Q2 2026.
BVF Inc sold 528,700 Mirum Pharmaceuticals shares in Q2 2026, an estimated $53.1M.
Mirum Pharmaceuticals made up 3.16% of BVF Inc's portfolio in Q2 2026, its #8 holding.
BVF Inc first reported a position in Mirum Pharmaceuticals in Q3 2021 and has held it in 14 quarters since.
BVF Inc's Mirum Pharmaceuticals position peaked at $149M in Q2 2024.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.